Qube Research & Technologies (QRT)
ACH

Qube Research & Technologies (QRT)’s Accendra Health ACH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-286,625
Closed -$3.87M – 3881
2024
Q2 		$3.87M Buy
286,625
+197,936
+223% +$4.05M 0.01% 1372
2024
Q1 		$2.46M Sell
88,689
-235,318
-73% -$5.23M ﹤0.01% 1636
2023
Q4 		$6.24M Buy
324,007
+123,268
+61% +$2.23M 0.01% 928
2023
Q3 		$3.24M Buy
200,739
+97,847
+95% +$1.74M 0.01% 1140
2023
Q2 		$1.96M Buy
102,892
+65,541
+175% +$1.17M 0.01% 1060
2023
Q1 		$543K Buy
+37,351
New +$669K ﹤0.01% 1540
2021
Q4 		– Sell
-38,613
Closed -$1.21M – 2852
2021
Q3 		$1.21M Buy
38,613
+7,789
+25% +$307K 0.02% 838
2021
Q2 		$1.3M Buy
30,824
+11,338
+58% +$441K 0.01% 840
2021
Q1 		$732K Buy
+19,486
New +$609K 0.01% 976
2020
Q3 		– Sell
-36,620
Closed -$279K – 1995
2020
Q2 		$279K Buy
+36,620
New +$268K ﹤0.01% 1331
2018
Q2 		– Sell
-1,287
Closed -$20K – 900
2018
Q1 		$20K Buy
+1,287
New +$22.9K 0.01% 306

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ACH Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Accendra Health (ACH) in Q3 2024, closing a stake of 286,625 shares — an estimated $3.87M sold.

Qube Research & Technologies (QRT) first reported a position in ACH in Q1 2018 and held it in 11 quarters. The position peaked at $6.24M in Q4 2023. 214 funds tracked by Wall St. Rank hold ACH as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Accendra Health position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 286,625 Accendra Health shares in Q3 2024, an estimated $3.87M.
  • Qube Research & Technologies (QRT) first reported a position in Accendra Health in Q1 2018 and held it in 11 quarters.
  • Qube Research & Technologies (QRT)'s Accendra Health position peaked at $6.24M in Q4 2023.
  • 214 funds tracked by Wall St. Rank held Accendra Health as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.